X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
https://www.globenewswire.com/news-release/2022/08/25/2504461/29446/en/U-S-Government-Exercises-Option-to-Purchase-Additional-RAPIVAB-peramivir-injection-from-BioCryst-for-Pandemic-Influenza-Preparedness.html
https://www.globenewswire.com/news-release/2021/09/01/2289871/29446/en/U-S-Government-Exercises-Option-to-Purchase-Additional-RAPIVAB-peramivir-injection-from-BioCryst-for-Delivery-to-Strategic-National-Stockpile.html
https://www.biospace.com/article/releases/biocryst-announces-fda-approval-of-supplemental-new-drug-application-for-rapivab-expanding-patient-population-to-include-children-six-months-and-older-/
https://endpts.com/biocryst-wins-approval-for-hae-pill-and-charges-half-a-million-dollars-but-will-anyone-take-it/
https://www.biospace.com/article/biocryst-announces-full-exercise-of-underwriters-option-to-purchase-additional-shares-and-completion-of-public-offering-of-common-stock-nov-18-2019/?s=95
https://globenewswire.com/news-release/2018/07/25/1542312/0/en/BioCryst-Announces-Publication-of-APeX-1-Clinical-Trial-Results-for-BCX7353-in-The-New-England-Journal-of-Medicine.html
https://www.pharmacompass.com/pdf/news/biocryst-uk-s-alpivab-peramivir-receives-approval-in-europe-1524718319.pdf
https://www.raps.org/news-and-articles/news-articles/2018/2/ema%E2%80%99s-chmp-recommends-five-new-medicines-for-appro?utm_source=Email&utm_medium=Informz&utm_campaign=Informz-Emails&_zs=VHOsL1&_zl=k7BK4
http://www.pharmatimes.com/news/five_new_medicines_backed_for_eu_approval_1223972
http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2018/02/news_detail_002907.jsp&mid=WC0b01ac058004d5c1
https://globenewswire.com/news-release/2017/10/04/1140521/0/en/BioCryst-Announces-RAPIVAB-peramivir-injection-and-Galidesivir-Presentations-at-IDWeek-2017.html
https://globenewswire.com/news-release/2017/09/21/1125740/0/en/BioCryst-s-RAPIVAB-peramivir-injection-Receives-FDA-Approval-for-a-Pediatric-Indication.html
http://www.fiercepharmaasia.com/story/australias-csls-rix-fp-phiii-meets-endpoint-firm-buys-rapivab-rights-biocry/2015-06-29
Market Place
Share 
